BioVectra
Charlottetown
About BioVectra
BioVectra manufactures ingredients for global pharmaceutical and biotechnology clients offering therapeutics used in the treatment of cancer, kidney disease, cardio-vascular disease, multiple sclerosis, and many other serious diseases. With over 40 years experience, the company is proficient in synthetic organic chemistry, fermentation of chemical and biologic molecules, downstream processing, MPEG production, and conjugation chemistry. BioVectra was founded on 1970 and is based in Charlottetown, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $77.3M
- Funding stage: M&A
- Last round: Grant (Nov 2021)
- Website: biovectra.com
- Phone: 866.883.2872
Industries & Categories
Biotechnology, Health Care, Manufacturing, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/biovectra-44728 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.